Spider Rock Advisors, LLC Novo Cure LTD Transaction History
Spider Rock Advisors, LLC
- $6.17 Billion
- Q3 2024
A detailed history of Spider Rock Advisors, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Spider Rock Advisors, LLC holds 80,693 shares of NVCR stock, worth $1.44 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
80,693
Previous 80,693
-0.0%
Holding current value
$1.44 Million
Previous $1.38 Million
8.76%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$217 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$212 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$142 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$77 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$54.2 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.88B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...